LABCORP HOLDINGS INC. Operating Income
LABCORP HOLDINGS INC. (LH) reported Operating Income of $451.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- LABCORP HOLDINGS INC. operating income (loss) for the quarter ending 2026-06-30 was $451.60M, a 14.47% increase year-over-year.
- LABCORP HOLDINGS INC. operating income (loss) for the quarter ending 2026-03-31 was $380.80M, a 16.81% increase year-over-year.
- LABCORP HOLDINGS INC. operating income (loss) for the quarter ending 2025-12-31 was $267.60M, a 23.60% increase year-over-year.
- LABCORP HOLDINGS INC. operating income (loss) for the quarter ending 2025-09-30 was $396.60M, a 56.08% increase year-over-year.
- LABCORP HOLDINGS INC. operating income (loss) for fiscal 2025 was $1.38B, a 27.42% increase from fiscal 2024.
- LABCORP HOLDINGS INC. operating income (loss) for fiscal 2024 was $1.09B, a 49.77% increase from fiscal 2023.
- LABCORP HOLDINGS INC. operating income (loss) for fiscal 2023 was $725.60M, a 49.49% decline from fiscal 2022.
- LABCORP HOLDINGS INC. operating income (loss) for fiscal 2022 was $1.44B, a 52.88% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 15 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $451.60M 10-Q · filed 2026-08-05 | $832.40M 10-Q · filed 2026-08-05 | $1.10B derived: sum of 3 quarters · filed 2026-08-05 | $1.50B derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2026-03-31 | $380.80M 10-Q · filed 2026-05-04 | $648.40M derived: sum of 2 quarters · filed 2026-05-04 | $1.04B derived: sum of 3 quarters · filed 2026-05-04 | $1.44B derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2025-12-31 | $267.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $664.20M derived: sum of 2 quarters · filed 2026-02-24 | $1.06B derived: sum of 3 quarters · filed 2026-08-05 | $1.38B 10-K · filed 2026-02-24 | |||||
| 2025-09-30 | $396.60M 10-Q · filed 2025-10-31 | $791.10M derived: sum of 2 quarters · filed 2026-08-05 | $1.12B 10-Q · filed 2025-10-31 | $1.33B derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2025-06-30 | $394.50M 10-Q · filed 2026-08-05 | $720.50M 10-Q · filed 2026-08-05 | $937.00M derived: sum of 3 quarters · filed 2026-08-05 | $1.19B derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2025-03-31 | $326.00M 10-Q · filed 2026-05-04 | $542.50M derived: sum of 2 quarters · filed 2026-05-04 | $796.60M derived: sum of 3 quarters · filed 2026-05-04 | $1.09B derived: sum of 4 quarters · filed 2026-05-04 | |||||
| 2024-12-31 | $216.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $470.60M derived: sum of 2 quarters · filed 2026-02-24 | $765.40M derived: sum of 3 quarters · filed 2026-02-24 | $1.09B 10-K · filed 2026-02-24 | |||||
| 2024-09-30 | $254.10M 10-Q · filed 2025-10-31 | $548.90M derived: sum of 2 quarters · filed 2025-10-31 | $870.20M 10-Q · filed 2025-10-31 | $747.40M derived: sum of 4 quarters · filed 2026-02-24 | |||||
| 2024-06-30 | $294.80M 10-Q · filed 2025-08-01 | $616.10M 10-Q · filed 2025-08-01 | $493.30M derived: sum of 3 quarters · filed 2026-02-24 | $745.60M derived: sum of 4 quarters · filed 2026-02-24 | |||||
| 2024-03-31 | $321.30M 10-Q · filed 2025-04-29 | $198.50M derived: sum of 2 quarters · filed 2026-02-24 | $450.80M derived: sum of 3 quarters · filed 2026-02-24 | $717.10M derived: sum of 4 quarters · filed 2026-02-24 | |||||
| 2023-12-31 | -$122.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $129.50M derived: sum of 2 quarters · filed 2026-02-24 | $395.80M derived: sum of 3 quarters · filed 2026-02-24 | $725.60M 10-K · filed 2026-02-24 | |||||
| 2023-09-30 | $252.30M 10-Q · filed 2024-10-29 | $518.60M derived: sum of 2 quarters · filed 2024-10-29 | $848.40M 10-Q · filed 2024-10-29 | $876.90M derived: sum of 4 quarters · filed 2025-02-25 | |||||
| 2023-06-30 | $266.30M 10-Q · filed 2024-08-02 | $596.10M 10-Q · filed 2024-08-02 | $624.60M derived: sum of 3 quarters · filed 2025-02-25 | $998.60M derived: sum of 4 quarters · filed 2025-02-25 | |||||
| 2023-03-31 | $329.80M 10-Q · filed 2024-04-30 | $341.00M 10-Q · filed 2023-05-04 | $358.30M derived: sum of 2 quarters · filed 2025-02-25 | $732.30M derived: sum of 3 quarters · filed 2025-02-25 | $1.16B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $28.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $402.50M derived: sum of 2 quarters · filed 2025-02-25 | $831.30M derived: sum of 3 quarters · filed 2025-02-25 | $1.44B 10-K · filed 2025-02-25 | $1.77B 10-K · filed 2023-02-28 | ||||
| 2022-09-30 | $374.00M 10-Q · filed 2023-10-30 | $469.40M 10-Q · filed 2022-11-01 | $802.80M derived: sum of 2 quarters · filed 2023-10-30 | $1.41B 10-Q · filed 2023-10-30 | $1.68B 10-Q · filed 2022-11-01 | $2.01B derived: sum of 4 quarters · filed 2024-02-26 | |||
| 2022-06-30 | $428.80M 10-Q · filed 2023-08-04 | $525.90M 10-Q · filed 2022-08-01 | $1.03B 10-Q · filed 2023-08-04 | $1.21B 10-Q · filed 2022-08-01 | $1.64B derived: sum of 3 quarters · filed 2024-02-26 | $2.40B derived: sum of 4 quarters · filed 2024-02-26 | |||
| 2022-03-31 | $687.90M 10-Q · filed 2023-05-04 | $1.21B derived: sum of 2 quarters · filed 2024-02-26 | $1.97B derived: sum of 3 quarters · filed 2024-02-26 | $2.68B derived: sum of 4 quarters · filed 2024-02-26 | |||||
| 2021-12-31 | $519.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $1.29B derived: sum of 2 quarters · filed 2024-02-26 | $1.99B derived: sum of 3 quarters · filed 2024-02-26 | $3.05B 10-K · filed 2024-02-26 | $3.26B 10-K · filed 2022-02-25 | ||||
| 2021-09-30 | $766.90M 10-Q · filed 2022-11-01 | $1.47B derived: sum of 2 quarters · filed 2022-11-01 | $2.53B 10-Q · filed 2022-11-01 | $3.82B derived: sum of 4 quarters · filed 2023-02-28 | |||||
| 2021-06-30 | $704.10M 10-Q · filed 2022-08-01 | $1.76B 10-Q · filed 2022-08-01 | $3.06B derived: sum of 3 quarters · filed 2023-02-28 | $4.10B derived: sum of 4 quarters · filed 2023-02-28 | |||||
| 2021-03-31 | $1.06B 10-Q · filed 2022-04-29 | $2.35B derived: sum of 2 quarters · filed 2023-02-28 | $3.40B derived: sum of 3 quarters · filed 2023-02-28 | $3.70B derived: sum of 4 quarters · filed 2023-02-28 | |||||
| 2020-12-31 | $1.29B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.34B derived: sum of 2 quarters · filed 2023-02-28 | $2.64B derived: sum of 3 quarters · filed 2023-02-28 | $2.45B 10-K · filed 2023-02-28 | |||||
| 2020-09-30 | $1.05B 10-Q · filed 2021-11-02 | $1.34B derived: sum of 2 quarters · filed 2021-11-02 | $1.15B 10-Q · filed 2021-11-02 | $1.49B derived: sum of 4 quarters · filed 2021-11-02 | |||||
| 2020-06-30 | $297.70M 10-Q · filed 2021-08-05 | $105.10M 10-Q · filed 2021-08-05 | $441.50M derived: sum of 3 quarters · filed 2021-08-05 | $781.40M derived: sum of 4 quarters · filed 2021-08-05 | |||||
| 2020-03-31 | -$192.60M 10-Q · filed 2021-05-04 | $143.80M derived: sum of 2 quarters · filed 2021-05-04 | $483.70M derived: sum of 3 quarters · filed 2021-05-04 | $819.40M derived: sum of 4 quarters · filed 2021-05-04 | |||||
| 2019-12-31 | $336.40M 10-K · filed 2020-02-28 | $676.30M derived: sum of 2 quarters · filed 2020-10-29 | $1.01B derived: sum of 3 quarters · filed 2020-10-29 | $1.33B 10-K · filed 2022-02-25 | |||||
| 2019-09-30 | $339.90M 10-Q · filed 2020-10-29 | $675.60M derived: sum of 2 quarters · filed 2020-10-29 | $993.80M 10-Q · filed 2020-10-29 | $1.30B derived: sum of 4 quarters · filed 2020-10-29 | |||||
| 2019-06-30 | $335.70M 10-Q · filed 2020-07-31 | $653.90M 10-Q · filed 2020-07-31 | $961.60M derived: sum of 3 quarters · filed 2020-07-31 | $1.30B derived: sum of 4 quarters · filed 2020-07-31 | |||||
| 2019-03-31 | $318.20M 10-Q · filed 2020-05-08 | $625.90M derived: sum of 2 quarters · filed 2020-05-08 | $969.30M derived: sum of 3 quarters · filed 2020-05-08 | $1.34B derived: sum of 4 quarters · filed 2020-05-08 | |||||
| 2018-12-31 | $307.70M 10-K · filed 2020-02-28 | $651.10M derived: sum of 2 quarters · filed 2020-02-28 | $1.02B derived: sum of 3 quarters · filed 2020-02-28 | $1.33B 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | $343.40M 10-K · filed 2020-02-28 | $712.60M derived: sum of 2 quarters · filed 2020-02-28 | $1.02B 10-Q · filed 2019-10-31 | $1.35B derived: sum of 4 quarters · filed 2020-02-28 | |||||
| 2018-06-30 | $369.20M 10-K · filed 2020-02-28 | $674.60M 10-Q · filed 2019-08-08 | $1.01B derived: sum of 3 quarters · filed 2020-02-28 | $1.33B derived: sum of 4 quarters · filed 2020-02-28 | |||||
| 2018-03-31 | $305.40M 10-K · filed 2020-02-28 | $636.00M derived: sum of 2 quarters · filed 2020-02-28 | $962.70M derived: sum of 3 quarters · filed 2020-02-28 | $1.29B derived: sum of 4 quarters · filed 2020-02-28 | |||||
| 2017-12-31 | $330.60M 10-K · filed 2019-02-28 | $657.30M derived: sum of 2 quarters · filed 2019-02-28 | $987.10M derived: sum of 3 quarters · filed 2019-02-28 | $1.31B 10-K · filed 2020-02-28 | $1.36B 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $326.70M 10-K · filed 2019-02-28 | $341.30M 10-Q · filed 2017-11-02 | $656.50M derived: sum of 2 quarters · filed 2019-02-28 | $974.60M 10-Q · filed 2018-10-30 | $1.01B 10-Q · filed 2017-11-02 | $1.26B derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | $329.80M 10-K · filed 2019-02-28 | $336.00M 10-Q · filed 2017-08-02 | $647.90M 10-Q · filed 2018-07-27 | $668.70M 10-Q · filed 2017-08-02 | $929.50M derived: sum of 3 quarters · filed 2019-02-28 | $1.25B derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $318.10M 10-K · filed 2019-02-28 | $332.70M 10-Q · filed 2017-04-28 | $599.70M derived: sum of 2 quarters · filed 2019-02-28 | $923.70M derived: sum of 3 quarters · filed 2019-02-28 | $1.29B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $281.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $605.60M derived: sum of 2 quarters · filed 2019-02-28 | $971.10M derived: sum of 3 quarters · filed 2019-02-28 | $1.27B 10-K · filed 2019-02-28 | $1.31B 10-K · filed 2017-02-27 | ||||
| 2016-09-30 | $324.00M 10-Q · filed 2017-11-02 | $689.50M derived: sum of 2 quarters · filed 2017-11-02 | $989.00M 10-Q · filed 2017-11-02 | $1.23B derived: sum of 4 quarters · filed 2018-02-27 | |||||
| 2016-06-30 | $365.50M 10-Q · filed 2017-08-02 | $366.90M 10-Q · filed 2016-07-29 | $665.00M 10-Q · filed 2017-08-02 | $668.80M 10-Q · filed 2016-07-29 | $901.50M derived: sum of 3 quarters · filed 2018-02-27 | $1.21B derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $299.50M 10-Q · filed 2017-04-28 | $301.90M 10-Q · filed 2016-05-06 | $536.00M derived: sum of 2 quarters · filed 2018-02-27 | $844.10M derived: sum of 3 quarters · filed 2018-02-27 | $1.17B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $236.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $544.60M derived: sum of 2 quarters · filed 2018-02-27 | $867.90M derived: sum of 3 quarters · filed 2018-02-27 | $996.80M 10-K · filed 2018-02-27 | $1.00B 10-K · filed 2016-02-29 | ||||
| 2015-09-30 | $308.10M 10-Q · filed 2016-10-28 | $306.90M 10-Q · filed 2015-10-30 | $631.40M derived: sum of 2 quarters · filed 2016-10-28 | $760.30M 10-Q · filed 2016-10-28 | $759.50M 10-Q · filed 2015-10-30 | $982.80M derived: sum of 4 quarters · filed 2016-10-28 | |||
| 2015-06-30 | $323.30M 10-Q · filed 2016-07-29 | $321.30M 10-Q · filed 2015-07-30 | $455.70M 10-Q · filed 2016-07-29 | $452.40M 10-Q · filed 2015-07-30 | $674.70M derived: sum of 3 quarters · filed 2016-07-29 | $916.10M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2015-03-31 | $132.40M 10-Q · filed 2016-05-06 | $130.20M 10-Q · filed 2015-05-04 | $351.40M derived: sum of 2 quarters · filed 2016-05-06 | $592.80M derived: sum of 3 quarters · filed 2016-05-06 | $839.50M derived: sum of 4 quarters · filed 2016-05-06 | ||||
| 2014-12-31 | $219.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $460.40M derived: sum of 2 quarters · filed 2016-03-01 | $707.10M derived: sum of 3 quarters · filed 2016-03-01 | $910.40M 10-K · filed 2016-03-01 | |||||
| 2014-09-30 | $241.40M 10-Q · filed 2015-10-30 | $488.10M derived: sum of 2 quarters · filed 2015-10-30 | $691.40M 10-Q · filed 2015-10-30 | $1.61B derived: sum of 4 quarters · filed 2017-02-27 | |||||
| 2014-06-30 | $246.70M 10-Q · filed 2015-07-30 | $450.00M 10-Q · filed 2015-07-30 | $1.37B derived: sum of 3 quarters · filed 2017-02-27 | $1.61B derived: sum of 4 quarters · filed 2017-02-27 | |||||
| 2014-03-31 | $904.30M 10-K · filed 2017-02-27 | $203.30M 10-Q · filed 2014-04-29 | $1.12B derived: sum of 2 quarters · filed 2017-02-27 | $1.36B derived: sum of 3 quarters · filed 2017-02-27 | $1.63B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2013-12-31 | $215.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $459.60M derived: sum of 2 quarters · filed 2016-03-01 | $728.90M derived: sum of 3 quarters · filed 2016-03-01 | $990.90M 10-K · filed 2016-03-01 | |||||
| 2013-09-30 | $244.60M 10-Q · filed 2014-11-10 | $513.90M derived: sum of 2 quarters · filed 2014-11-10 | $775.90M 10-Q · filed 2014-11-10 | $991.20M derived: sum of 4 quarters · filed 2015-02-26 | $245.10M 10-Q · filed 2013-10-28 | ||||
| 2013-06-30 | $269.30M 10-Q · filed 2014-07-29 | $531.30M 10-Q · filed 2014-07-29 | $746.60M derived: sum of 3 quarters · filed 2015-02-26 | $991.70M derived: sum of 4 quarters · filed 2015-02-26 | |||||
| 2013-03-31 | $262.00M 10-Q · filed 2014-04-29 | $477.30M derived: sum of 2 quarters · filed 2015-02-26 | $722.40M derived: sum of 3 quarters · filed 2015-02-26 | $998.40M derived: sum of 4 quarters · filed 2015-02-26 | |||||
| 2012-12-31 | $215.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $460.40M derived: sum of 2 quarters · filed 2015-02-26 | $736.40M derived: sum of 3 quarters · filed 2015-02-26 | $1.02B 10-K · filed 2015-02-26 | |||||
| 2012-09-30 | $245.10M 10-Q · filed 2012-10-30 | $521.10M derived: sum of 2 quarters · filed 2013-07-30 | $808.20M 10-Q · filed 2013-10-28 | $1.06B derived: sum of 4 quarters · filed 2014-02-25 | |||||
| 2012-06-30 | $276.00M 10-Q · filed 2013-07-30 | $563.10M 10-Q · filed 2013-07-30 | $810.60M derived: sum of 3 quarters · filed 2014-02-25 | $1.05B derived: sum of 4 quarters · filed 2014-02-25 | |||||
| 2012-03-31 | $287.10M 10-Q · filed 2013-05-01 | $534.60M derived: sum of 2 quarters · filed 2014-02-25 | $774.00M derived: sum of 3 quarters · filed 2014-02-25 | $999.70M derived: sum of 4 quarters · filed 2014-02-25 | |||||
| 2011-12-31 | $247.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $486.90M derived: sum of 2 quarters · filed 2014-02-25 | $712.60M derived: sum of 3 quarters · filed 2014-02-25 | $948.40M 10-K · filed 2014-02-25 | |||||
| 2011-09-30 | $239.40M 10-Q · filed 2012-10-30 | $465.10M derived: sum of 2 quarters · filed 2012-10-30 | $700.90M 10-Q · filed 2012-10-30 | $939.70M derived: sum of 4 quarters · filed 2013-02-26 | |||||
| 2011-06-30 | $225.70M 10-Q · filed 2012-08-02 | $461.50M 10-Q · filed 2012-08-02 | $700.30M derived: sum of 3 quarters · filed 2013-02-26 | $935.60M derived: sum of 4 quarters · filed 2013-02-26 | |||||
| 2011-03-31 | $235.80M 10-Q · filed 2012-04-27 | $474.60M derived: sum of 2 quarters · filed 2013-02-26 | $709.90M derived: sum of 3 quarters · filed 2013-02-26 | $980.40M derived: sum of 4 quarters · filed 2013-02-26 | |||||
| 2010-12-31 | $238.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $474.10M derived: sum of 2 quarters · filed 2013-02-26 | $744.60M derived: sum of 3 quarters · filed 2013-02-26 | $978.80M 10-K · filed 2013-02-26 | |||||
| 2010-09-30 | $235.30M 10-Q · filed 2011-10-31 | $505.80M derived: sum of 2 quarters · filed 2011-10-31 | $740.00M 10-Q · filed 2011-10-31 | $955.80M derived: sum of 4 quarters · filed 2012-02-24 | |||||
| 2010-06-30 | $270.50M 10-Q · filed 2011-08-02 | $504.70M 10-Q · filed 2011-08-02 | $720.50M derived: sum of 3 quarters · filed 2012-02-24 | $955.40M derived: sum of 4 quarters · filed 2012-02-24 | |||||
| 2010-03-31 | $234.20M 10-Q · filed 2011-05-04 | $450.00M derived: sum of 2 quarters · filed 2012-02-24 | $684.90M derived: sum of 3 quarters · filed 2012-02-24 | $929.60M derived: sum of 4 quarters · filed 2012-02-24 | |||||
| 2009-12-31 | $215.80M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | $450.70M derived: sum of 2 quarters · filed 2012-02-24 | $695.40M derived: sum of 3 quarters · filed 2012-02-24 | $935.90M 10-K · filed 2012-02-24 | |||||
| 2009-09-30 | $234.90M 10-Q · filed 2010-11-01 | $479.60M derived: sum of 2 quarters · filed 2010-11-01 | $720.10M 10-Q · filed 2010-11-01 | $924.50M derived: sum of 4 quarters · filed 2011-03-07 | |||||
| 2009-06-30 | $244.70M 10-Q/A · filed 2010-08-20 | $485.20M 10-Q/A · filed 2010-08-20 | $689.60M derived: sum of 3 quarters · filed 2011-03-07 | $891.80M derived: sum of 4 quarters · filed 2011-03-07 | |||||
| 2009-03-31 | $240.50M 10-Q · filed 2010-04-28 | $444.90M derived: sum of 2 quarters · filed 2011-03-07 | $647.10M derived: sum of 3 quarters · filed 2011-03-07 | $842.30M derived: sum of 4 quarters · filed 2011-03-07 | |||||
| 2008-12-31 | $204.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2011-03-07 | $406.60M derived: sum of 2 quarters · filed 2011-03-07 | $601.80M derived: sum of 3 quarters · filed 2011-03-07 | $842.90M 10-K/A · filed 2011-03-07 | |||||
| 2008-09-30 | $202.20M 10-Q · filed 2009-10-29 | $397.40M derived: sum of 2 quarters · filed 2009-10-29 | $638.50M 10-Q · filed 2009-10-29 | ||||||
| 2008-06-30 | $195.20M 10-Q/A · filed 2009-08-28 | $436.30M 10-Q/A · filed 2009-08-28 | |||||||
| 2007-12-31 | $777.00M 10-K · filed 2010-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |